A detailed history of Squarepoint Ops LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 13,500 shares of RVMD stock, worth $584,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,500
Holding current value
$584,415
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$20.28 - $27.0 $541,050 - $720,333
26,679 New
26,679 $713,000
Q4 2022

Feb 14, 2023

BUY
$17.68 - $25.53 $340,711 - $491,988
19,271 New
19,271 $459,000
Q3 2021

Nov 15, 2021

SELL
$23.95 - $33.41 $3.49 Million - $4.87 Million
-145,886 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$29.0 - $47.44 $4.23 Million - $6.92 Million
145,886 New
145,886 $4.63 Million
Q1 2021

May 17, 2021

SELL
$37.21 - $54.43 $524,437 - $767,136
-14,094 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$30.19 - $45.49 $425,497 - $641,136
14,094 New
14,094 $558,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.